<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04723355</url>
  </required_header>
  <id_info>
    <org_study_id>40422220.1.0000.5462</org_study_id>
    <nct_id>NCT04723355</nct_id>
  </id_info>
  <brief_title>A Comparative Study of the QuoreOne Holter System and the Cardiolight Holter System</brief_title>
  <official_title>A Comparative Study of the Findings of Dynamic Electrocardiography (Holter System) Using the QuoreOne System From QuoreTech and the Cardiolight System From Cardios</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto Dante Pazzanese de Cardiologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Quoretech</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Israelita Albert Einstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Holter monitoring is one of the most widely used diagnostic methods to detect cardiac&#xD;
      arrhythmias. Newer Holter monitors may provide some advantages over the more traditional&#xD;
      ones. This study will compare the findings of a Holter exam using the QuoreOne system from&#xD;
      QuoreTech with the traditional Cardiolight system from Cardios.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The 24-hour ambulatory electrocardiography, commonly known as Holter monitoring, is a&#xD;
      diagnostic method to correlate clinical symptoms with cardiac arrhythmias. The Holter monitor&#xD;
      records electrical signals from the heart using electrodes attached to the chest, which are&#xD;
      connected via cables to a digital recorder. In addition to the device to record the cardiac&#xD;
      electrical signals, the Holter system also has a software for review and analysis of the&#xD;
      record. The software of the Holter system has an integrated automatic analysis process to&#xD;
      detect different sorts of heart beats, rhythms, etc, which are then validated by a technician&#xD;
      and a physician. The success of the automatic analysis depends of the quality of the captured&#xD;
      electrical signals, which are dependent on the appropriate attachment of the&#xD;
      electrodes/cables to the patient body. Therefore, inappropriately attached electrodes/cables&#xD;
      can result in electromagnetic disturbance that can interfere with the ECG signal, resulting&#xD;
      in a very noisy record that is hard to be analysed.&#xD;
&#xD;
      Newer Holter systems that eliminate the cables and attach the recorder directly to the&#xD;
      electrodes positioned in the patient´s chest might reduce the electromagnetic disturbance in&#xD;
      the ECG signal capture and, therefore, improve the quality of the exam.&#xD;
&#xD;
      This study will compare the findings of a Holter exam using a newer system, the QuoreOne&#xD;
      system from QuoreTech, with a more traditional system, the Cardiolight system from Cardios.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 26, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of cardiac arrhythmias</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with cardiac arrhythmias detected in both Holter monitors, including a) atrial fibrillation or atrial flutter; b) supraventricular tachycardia (≥ 3 beats); c) ventricular tachycardia (≥ 3 beats); d) polymorphic ventricular tachycardia or ventricular fibrillation; e) atrioventricular block (2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block); or f) heart beat pauses (≥ 2,5 seconds)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of atrial fibrillation or atrial flutter</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with atrial fibrillation or atrial flutter detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of supraventricular tachycardia</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with supraventricular tachycardia (≥ 3 beats) detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of ventricular tachycardia</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with ventricular tachycardia (≥ 3 beats) detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of polymorphic ventricular tachycardia or ventricular fibrillation</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with polymorphic ventricular tachycardia or ventricular fibrillation detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of atrioventricular block</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with atrioventricular block, including 2nd degree AV block Mobitz type I and II, AV block 2:1 or complete AV block, detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of heart beat pauses</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with heart beat pauses ≥ 2.5 seconds detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the Holter exam</measure>
    <time_frame>24 hours</time_frame>
    <description>Duration of the Holter exam in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medium heart rate</measure>
    <time_frame>24 hours</time_frame>
    <description>Medium heart rate measured in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum heart rate</measure>
    <time_frame>24 hours</time_frame>
    <description>Maximum heart rate measured in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum heart rate</measure>
    <time_frame>24 hours</time_frame>
    <description>Minimum heart rate measured in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial ectopic heart beats</measure>
    <time_frame>24 hours</time_frame>
    <description>Total number of atrial ectopic heart beats measured in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular ectopic heart beats</measure>
    <time_frame>24 hours</time_frame>
    <description>Total number of ventricular ectopic heart beats measured in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episodes of ventricular tachycardia</measure>
    <time_frame>24 hours</time_frame>
    <description>Total number of ventricular tachycardia episodes detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episodes of supraventricular tachycardia</measure>
    <time_frame>24 hours</time_frame>
    <description>Total number of supraventricular tachycardia episodes detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episodes of heart beat pauses</measure>
    <time_frame>24 hours</time_frame>
    <description>Total number of heart beat pauses ≥ 2.5 seconds detected in both Holter monitors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Holter system convenience of use</measure>
    <time_frame>24 hours</time_frame>
    <description>Patient self-reported evaluation of convenience of using each of the Holter monitors</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">182</enrollment>
  <condition>Cardiac Arrhythmia</condition>
  <arm_group>
    <arm_group_label>QuoreOne</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this single arm of the study, the participant will use 2 Holter systems simultaneously for 24 hours, the QuoreOne system from QuoreTech and the Cardiolight system from Cardios.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>QuoreOne Holter system</intervention_name>
    <description>The participant will use the QuoreOne Holter system simultaneously with the Cardiolight Holter system for 24 hours.</description>
    <arm_group_label>QuoreOne</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiolight Holter system</intervention_name>
    <description>The participant will use the Cardiolight Holter system simultaneously with the QuoreOne Holter system for 24 hours.</description>
    <arm_group_label>QuoreOne</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any individual who has an indication of 24 hours Holter monitoring and is referred to&#xD;
             the arrhythmia clinic of the Instituto Dante Pazzanese de Cardiologia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to provide written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karla Santo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Israelita Albert Einstein</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karla Santo, PhD</last_name>
    <phone>+551121515915</phone>
    <email>karla.santo@einstein.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luciana Piano, PhD</last_name>
    <email>luciana.piano@einstein.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardiologia</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Paiva</last_name>
    </contact>
    <investigator>
      <last_name>Dalmo AR Moreira, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will be shared upon review of a request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

